232 related articles for article (PubMed ID: 36130486)
1. Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor.
Zhang X; Lou HE; Gopalan V; Liu Z; Jafarah HM; Lei H; Jones P; Sayers CM; Yohe ME; Chittiboina P; Widemann BC; Thiele CJ; Kelly MC; Hannenhalli S; Shern JF
Cell Rep; 2022 Sep; 40(12):111363. PubMed ID: 36130486
[TBL] [Abstract][Full Text] [Related]
2. The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.
Zhang X; Murray B; Mo G; Shern JF
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182803
[TBL] [Abstract][Full Text] [Related]
3. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state.
Kochat V; Raman AT; Landers SM; Tang M; Schulz J; Terranova C; Landry JP; Bhalla AD; Beird HC; Wu CC; Jiang Y; Mao X; Lazcano R; Gite S; Ingram DR; Yi M; Zhang J; Keung EZ; Scally CP; Roland CL; Hunt KK; Feig BW; Futreal PA; Hwu P; Wang WL; Lazar AJ; Slopis JM; Wilson-Robles H; Wiener DJ; McCutcheon IE; Wustefeld-Janssens B; Rai K; Torres KE
Acta Neuropathol; 2021 Sep; 142(3):565-590. PubMed ID: 34283254
[TBL] [Abstract][Full Text] [Related]
4. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
[TBL] [Abstract][Full Text] [Related]
5. Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss.
Marchione DM; Lisby A; Viaene AN; Santi M; Nasrallah M; Wang LP; Williams EA; Larque AB; Chebib I; Garcia BA; Wojcik JB
Mod Pathol; 2019 Oct; 32(10):1434-1446. PubMed ID: 31175328
[TBL] [Abstract][Full Text] [Related]
6. Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside.
Korfhage J; Lombard DB
Mol Cancer Res; 2019 Jul; 17(7):1417-1428. PubMed ID: 31023785
[TBL] [Abstract][Full Text] [Related]
7.
Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
[TBL] [Abstract][Full Text] [Related]
8. Epigenomic Reordering Induced by Polycomb Loss Drives Oncogenesis but Leads to Therapeutic Vulnerabilities in Malignant Peripheral Nerve Sheath Tumors.
Wojcik JB; Marchione DM; Sidoli S; Djedid A; Lisby A; Majewski J; Garcia BA
Cancer Res; 2019 Jul; 79(13):3205-3219. PubMed ID: 30898839
[TBL] [Abstract][Full Text] [Related]
9. PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.
Patel AJ; Warda S; Maag JLV; Misra R; Miranda-Román MA; Pachai MR; Lee CJ; Li D; Wang N; Bayshtok G; Fishinevich E; Meng Y; Wong EWP; Yan J; Giff E; Pappalardi MB; McCabe MT; Fletcher JA; Rudin CM; Chandarlapaty S; Scandura JM; Koche RP; Glass JL; Antonescu CR; Zheng D; Chen Y; Chi P
Cancer Discov; 2022 Sep; 12(9):2120-2139. PubMed ID: 35789380
[TBL] [Abstract][Full Text] [Related]
10. Polycomb repression regulates Schwann cell proliferation and axon regeneration after nerve injury.
Ma KH; Duong P; Moran JJ; Junaidi N; Svaren J
Glia; 2018 Nov; 66(11):2487-2502. PubMed ID: 30306639
[TBL] [Abstract][Full Text] [Related]
11. [PRC2 alterations in NF1-associated malignant peripheral nerve sheath tumors: schwann cells with no complex].
Luscan A; Vidaud D; Ortonne N; Wolkenstein P; Vidaud M; Pasmant E
Med Sci (Paris); 2014; 30(8-9):733-5. PubMed ID: 25174745
[No Abstract] [Full Text] [Related]
12. PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation.
Ren Z; Ahn JH; Liu H; Tsai YH; Bhanu NV; Koss B; Allison DF; Ma A; Storey AJ; Wang P; Mackintosh SG; Edmondson RD; Groen RWJ; Martens AC; Garcia BA; Tackett AJ; Jin J; Cai L; Zheng D; Wang GG
Blood; 2019 Oct; 134(14):1176-1189. PubMed ID: 31383640
[TBL] [Abstract][Full Text] [Related]
13. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies.
De Raedt T; Beert E; Pasmant E; Luscan A; Brems H; Ortonne N; Helin K; Hornick JL; Mautner V; Kehrer-Sawatzki H; Clapp W; Bradner J; Vidaud M; Upadhyaya M; Legius E; Cichowski K
Nature; 2014 Oct; 514(7521):247-51. PubMed ID: 25119042
[TBL] [Abstract][Full Text] [Related]
14. Snail2/Slug cooperates with Polycomb repressive complex 2 (PRC2) to regulate neural crest development.
Tien CL; Jones A; Wang H; Gerigk M; Nozell S; Chang C
Development; 2015 Feb; 142(4):722-31. PubMed ID: 25617436
[TBL] [Abstract][Full Text] [Related]
15. PRC2 loss amplifies Ras signaling in cancer.
Baude A; Lindroth AM; Plass C
Nat Genet; 2014 Nov; 46(11):1154-5. PubMed ID: 25352098
[TBL] [Abstract][Full Text] [Related]
16. The Multiple Facets of PRC2 Alterations in Cancers.
Wassef M; Margueron R
J Mol Biol; 2017 Jun; 429(13):1978-1993. PubMed ID: 27742591
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells.
Brien GL; Bressan RB; Monger C; Gannon D; Lagan E; Doherty AM; Healy E; Neikes H; Fitzpatrick DJ; Deevy O; Grant V; Marqués-Torrejón MA; Alfazema N; Pollard SM; Bracken AP
Nat Genet; 2021 Aug; 53(8):1221-1232. PubMed ID: 34294917
[TBL] [Abstract][Full Text] [Related]
18. A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming.
Chan YS; Göke J; Lu X; Venkatesan N; Feng B; Su IH; Ng HH
Stem Cells; 2013 Apr; 31(4):682-92. PubMed ID: 23280602
[TBL] [Abstract][Full Text] [Related]
19. PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma.
Shivram H; Le SV; Iyer VR
PLoS One; 2019; 14(9):e0222435. PubMed ID: 31513636
[TBL] [Abstract][Full Text] [Related]
20. Polycomb complexes redundantly maintain epidermal stem cell identity during development.
Cohen I; Bar C; Liu H; Valdes VJ; Zhao D; Galbo PM; Silva JM; Koseki H; Zheng D; Ezhkova E
Genes Dev; 2021 Mar; 35(5-6):354-366. PubMed ID: 33602871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
